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Digital  PCR  for quantiﬁcation  of a target  of  interest  has  been  independently  developed  several  times,
being  described  in  1990  and  1991  using  the term  “limiting  dilution  PCR”  and  in 1999  using the  termccepted  20 June 2014




“digital  PCR”.  It  came  into  use  in  the  decade  following  its ﬁrst  development  but its  use  was  cut  short
by  the  description  of  real-time  PCR  in 1996.  However  digital  PCR  has now  had a  renaissance  due  to the
recent  development  of new  instruments  and chemistry  which  have  made  it a much  simpler  and  more
practical  technique.
© 2014  Published  by  Elsevier  GmbH. Open access under CC BY-NC-ND license.CR
The term “digital PCR” was ﬁrst used in the 1999 paper by Kinzler
nd Vogelstein [1] in which they described the quantitation of ras
utations in a sample by partitioning the sample in order to per-
orm a series of PCRs in 384 well microplates. The term “digital PCR”
as very apposite as it captured both the nature of the reaction and
he spirit of the times and it immediately became established. How-
ver the method that they described was not new as it had been
sed over the previous decade under the terms “single molecule
CR” or “limiting dilution PCR”. They referenced single molecule
CR but not quantitation by limiting dilution PCR.
In  broad terms, classical PCR can be used for a qualitative or
 quantitative purpose, either to study the properties of a tar-
et molecule or to determine the number of a target molecule.
igital PCR is used similarly, the difference being that in digital
CR the sample is partitioned to the level of single molecules, PCR
mpliﬁcation is then performed, an all-or-none, i.e. digital, signal is
btained and either the nature of the target molecule is analysed or
he number of the target molecule is calculated using the Poisson
istribution.
To my  knowledge, Saiki et al. [2], in an important early study
f PCR published in 1988, were the ﬁrst to use this approach. They
imit diluted a sample of genomes containing B-globin genes in a
ample of genomes from which the -globin gene had been deleted,
nd showed that single -globin molecules could be ampliﬁed and
etected. The frequency of positive ampliﬁcations when analysed
y the Poisson distribution suggested that virtually every -globin
olecule was ampliﬁable by the PCR. They were thus the ﬁrst to
se PCR to isolate and analyse a single molecule but they did not
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detection of single molecules as a tool for quantiﬁcation.
The ability of PCR to amplify a single molecule for analysis was
soon recognised and exploited. In 1990 Jeffreys et al. [3] published
on the use of single molecule PCR to study minisatellite evolution
and Ruano et al. [4] published on the use of single molecule PCR
to analyse haplotyping. Single molecule PCR continues to be a use-
ful approach to study a target of interest. I searched Medline and
Google Scholar using the search terms of “single molecule” and
“PCR”, and found 4–10 publications annually in subsequent years.
“Single molecule PCR” is probably a more descriptive term than
“digital PCR” when referring to the process of PCR cloning of a tar-
get molecule in order to perform qualitative analysis, as it refers to
the target molecule rather than to the signal.
The ﬁrst publication on the use of digital PCR to quantify a tar-
get of interest, in this case HIV, was that by Simmonds et al. [5]
in 1990 and I am indebted to Professor Simmonds for informa-
tion on the background. The group was interested in determining
the genetic diversity of HIV populations infecting lymphocytes in
blood samples from HIV-positive individuals but recognised that
study of bulk samples would prevent study of sequence differences
between individual proviral molecules. Limiting dilution followed
by PCR of replicates and sequencing of positives was performed
(another early example of single molecule PCR). It soon became
evident that the frequency of positive ampliﬁcations followed the
Poisson distribution and that, conversely, the number of target HIV
provirus molecules in the original sample could be calculated from
the degree of dilution and the frequency of negative (or positive)
ampliﬁcations. The original publication described the limiting dilu-
tion of both mononuclear cells and provirus molecules and in this
way documented the number of cells carrying HIV provirus and
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ears the group continued to use limiting dilution PCR in a number
f follow-up studies of HIV and HCV.
Limiting dilution PCR was developed contemporaneously and
ndependently by our own  group. It involved the conjunction of two
ines of research. In one line of research we had been using genetic
election and lymphocyte cloning to study human somatic muta-
ions at the X-linked HPRT and autosomal HLA loci. Cell cloning
as used to amplify the rare mutant cells, Poisson statistics was
sed to quantify their number and DNA sequencing was used to
nalyse the nature of individual mutated genes. The second line of
esearch was our development of a PCR-based method to identify
nd sequence the rearranged and mutated immunoglobulin heavy
hain (IGH) genes which can serve as clonal markers for neoplas-
ic lymphocyte clones in leukaemia. It was a natural step to merge
hese two lines of research and to isolate and sequence the rear-
anged IGH gene molecule at the time of diagnosis in a patient
ith leukaemia, synthesise primers speciﬁc for the rearrangement,
nd to use these primers and limiting dilution PCR to quantify the
arker IGH rearrangement and hence quantify the leukaemic cells
n samples obtained during treatment. A publication brieﬂy men-
ioning this method appeared in 1991 [6]. However, recognizing
he general utility of this method for quantiﬁcation of DNA targets,
e published a deﬁnitive study of the method in 1992 [7] in a gen-
ral biological journal. We  continued to use limiting dilution PCR
o study various aspects of treatment and biology of acute lym-
hoblastic leukaemia (ALL). The most important study was a 1994
aper in the Lancet which showed that outcome in childhood ALL
ould be predicted by the level of leukaemia after one month of
herapy [8], and treatment decisions based on this form of assess-
ent have now become part of routine management of childhood
LL.
Limiting dilution PCR was an improvement over previous tech-
iques, such as competitive PCR, for quantiﬁcation of PCR targets.
t was precise, had a wide dynamic range, and could detect and
uantify rare target molecules. However it had two disadvantages.
irstly, it was an open system and had the potential for contamina-
ion of the environment by ampliﬁed PCR product. Secondly, it was
 manual system and quite laborious. Our protocol was to perform
n initial series of PCRs involving three replicates at tenfold dilu-
ions of the sample in order to approximately determine the limit
f dilution and then to perform a deﬁnitive series of PCRs involv-
ng 5–10 replicates at each of a series of threefold dilutions around
he limit of dilution. The endpoint of all-or-none ampliﬁcation was
ssessed by electrophoresis.
Search  of Medline and Google Scholar using the terms “limiting
ilution” and “PCR” showed that the number of publications using
imiting dilution PCR increased to a peak of 12 publications per
ear in 1999. The publications were chieﬂy, but not entirely, in
he areas of virology and lymphoid biology and neoplasia, pre-
umably because workers in these two ﬁelds were more likely
o have become aware of the technique. However between 2000
nd 2002 the annual publication rate fell steeply, and publications
sing limiting dilution PCR virtually disappeared thereafter. This
as undoubtedly due to publication of the method of real-time
uantitative PCR by Heid et al. [9]. Real-time PCR is a closed method
nd is technically simple and these features overcome the two dis-
dvantages of limiting dilution PCR. Our group gratefully switched
rom limiting dilution PCR to real-time PCR as soon as we became
ware of real time PCR.
The  method for digital PCR as described by Vogelstein and Kin-
ler used ﬂuorescence as the endpoint, obviating electrophoresis.
t thus had an advantage over the method as previously performed.
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However  it was still somewhat laborious and, as it was compet-
ing against real-time PCR, it did not come into widespread use.
Search of Medline and Google Scholar using the term “digital PCR”
showed that the publication rate remained low, at several publi-
cations per year, until 2007. However from that year on there has
been a rapid and exponential increase in the number of publications
referring to digital PCR. At ﬁrst these publications were predomi-
nantly in engineering and microﬂuidics journals but during the last
few years there has been an increasing number of publications in
biological and medical journals. This rapid rise in publication rate is
obviously due to the development of new instrumentation which
makes digital PCR a relatively simple and practical method.
The  history of the development of digital PCR has several gen-
eral lessons. Firstly, it shows the value of using a title that is
both descriptive and catchy. Both “limiting dilution” and “digi-
tal” are descriptive – “limiting dilution” describes the process of
arriving at single molecules, “digital” describes the nature of the
signal – but “digital” is in accord with the electronic nature of the
times. Secondly, the method was invented several times by work-
ers unaware of its existence in another ﬁeld, despite the availability
of searchable electronic databases. Presumably this lack of knowl-
edge resulted from the magnitude of the scientiﬁc literature and
the publication of methods in specialty journals. A corollary of
these general factors is that workers in one ﬁeld may be quite dis-
advantaged if they are not aware of a useful method in another
ﬁeld and, conversely, cross-communication between workers in
different ﬁelds can be very fruitful. Thirdly, the history of digital
PCR shows that a method may  in large part be “ahead of its time”
and may  require advances in other ﬁelds such as engineering and
chemistry to allow its full ﬂowering.
Finally, what will be the future history of digital PCR? Will its
use continue to expand exponentially? Will considerations of cost
and throughput be overcome? What will be its place relative to
real-time PCR and next-generation sequencing? Will other digi-
tal or non-digital non-PCR methods for detection be developed?
Already digital PCR for rare targets can sometimes be performed
using current instruments for real-time PCR, and next-generation
sequencing can be used both for single molecule analysis and target
quantiﬁcation. Undoubtedly, the coming years will be both inter-
esting and productive.
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